CTRP3 is a novel biomarker for diabetic retinopathy and inhibits HGHL-induced VCAM-1 expression in an AMPK-dependent manner.

Yan, Zheyi

CTRP3 is a novel biomarker for diabetic retinopathy and inhibits HGHL-induced VCAM-1 expression in an AMPK-dependent manner. [electronic resource] - PloS one 2017 - e0178253 p. digital

Publication Type: Journal Article

1932-6203

10.1371/journal.pone.0178253 doi


AMP-Activated Protein Kinases--metabolism
Biomarkers--metabolism
Case-Control Studies
Cells, Cultured
Collagen--metabolism
Diabetes Mellitus, Type 2--complications
Diabetic Retinopathy--diagnosis
Endothelium, Vascular--cytology
Female
Glucose--adverse effects
Humans
Lipids--adverse effects
Male
Middle Aged
Retinal Vessels--cytology
Tumor Necrosis Factors--metabolism
Vascular Cell Adhesion Molecule-1--metabolism